Printer Friendly
The Free Library
14,505,983 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Few infectious complications after BMT for breast cancer.


Women who undergo autologous bone marrow transplantation autologous bone marrow transplantation Transplantation medicine The administration to an individual 'X' of his/her own BM, often to a leukemic Pt in relapse who, because a suitable HLA-matched donor is not available, would otherwise die of the disease. See Bone marrow.  (BMT) or peripheral stem cell transplantation peripheral stem cell transplantation Peripheral stem cell support Oncology A method of replacing hematopoietic cells–HCs destroyed by chemotherapy; stem cells in circulating blood are removed before treatment, then readministered treatment to help BM recovery  (PSCT) plus high-dose chemotherapy for breast cancer experience few infectious complications, according to researchers at the University of Pennsylvania Medical Center in Philadelphia.

In their study of 127 women, the investigators found bacteremia, caused by a variety of gram-positive and gram-negative bacteria, was the most common infection immediately posttransplant, occurring in 13% of patients. Clostridium difficile colitis Clostridium difficile colitis Infectious disease Colonic infection by C difficile Clinical Some are asymptomic and become C difficile carriers; more commonly, diarrhea, abdominal pain, colitis, fever, vomiting dehydration; if severe, pseudomembranous  and urinary tract infection urinary tract infection (UTI),
n infection in one or more of the structures that make up the urinary system. Occurs more often in women and is most commonly caused by bacteria.
 were other causes of early infections following BMT or PSCT. Most infections during hospitalization (16%) were catheter-related, although 11% of patients developed mucocutaneous mucocutaneous /mu·co·cu·ta·ne·ous/ (-ku-ta´ne-us) pertaining to or affecting the mucous membrane and the skin.

mu·co·cu·ta·ne·ous
adj.
Of or relating to the skin and a mucous membrane.
 candidiasis.

Among the 32 patients who developed infections after hospital discharge, upper respiratory tract infections and dermatomal zoster dominated. Viral and fungal infections were uncommon after transplantation, and only 4 patients required hospitalization for infectious complications during the year of study follow-up. Clinical Infectious Disease 2001;32:391-395.
COPYRIGHT 2001 Transplant Communications, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Comment:Few infectious complications after BMT for breast cancer.
Publication:Transplant News
Geographic Code:1USA
Date:Mar 16, 2001
Words:145
Previous Article:Lung transplantation can be effective in CF patients with B. cepacia.(Brief Article)(Statistical Data Included)
Next Article:High-dose therapy plus BMT improve survival in follicular lymphoma patients.
Topics:



Related Articles
New genetic techniques eliminate guesswork in matching unrelated BMTs for treatment of leukemia.
Fred Hutchinson Cancer Research Center leading research for kinder, gentler bone marrow transplant procedure using no high-dose chemotherapy or...
Preliminary data shows HDC+BMT combo therapy doesn't affect breast cancer survival rate; results questioned.
HDC+BMT treatment option for breast cancer patients should continue to be evaluated, NCI researchers say.
Sexual Function Measurement and Outcomes in Cancer Survivors and Matched Controls.(Statistical Data Included)
Fred Hutchinson Cancer Center hit with class action lawsuit by families over BMT trial.(Brief Article)
Patients' sense of well-being diminished after autologous BMT.(bone marrow transplant research)(Brief Article)
CYTOGEN LAUNCHES SOLTAMOX ORAL LIQUID FOR BREAST CANCER.
Chemoprevention: A 21st century shell game?
WEILL CORNELL IDENTIFIES DRUG TARGETS FOR BREAST CANCER.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles